Literature DB >> 12962224

Antagonistic activity of Aeromonas media strain A199 against Saprolegnia sp., an opportunistic pathogen of the eel, Anguilla australis Richardson.

M J Lategan1, L F Gibson.   

Abstract

A bacteriocin-like inhibitory substance (BLIS) produced by Aeromonas media strain A199 inhibited the growth of Saprolegnia sp. in vitro, an opportunistic pathogen isolated from affected eels, Anguilla australis (Richardson). The presence of BLIS in solid media inhibited the growth of the vegetative state of the aquatic mould as well as the germination of cysts. Uninhibited growth was, however, observed in the presence of inactive BLIS, suggesting that the in vitro antagonism derived from the BLIS of A199. In four independent in vivo tank observations of fish affected with saprolegniosis, the daily addition of A199 to tank water contributed to the subsequent swift recovery of affected hosts from invasion by this opportunistic pathogen.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12962224     DOI: 10.1046/j.1365-2761.2003.00443.x

Source DB:  PubMed          Journal:  J Fish Dis        ISSN: 0140-7775            Impact factor:   2.767


  3 in total

1.  Diversity of Aquatic Pseudomonas Species and Their Activity against the Fish Pathogenic Oomycete Saprolegnia.

Authors:  Yiying Liu; Elzbieta Rzeszutek; Menno van der Voort; Cheng-Hsuan Wu; Even Thoen; Ida Skaar; Vincent Bulone; Pieter C Dorrestein; Jos M Raaijmakers; Irene de Bruijn
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

Review 2.  Evolution of probiotics in aquatic world: Potential effects, the current status in Egypt and recent prospectives.

Authors:  Mai D Ibrahem
Journal:  J Adv Res       Date:  2013-12-11       Impact factor: 10.479

3.  Elucidating the Diversity of Aquatic Microdochium and Trichoderma Species and Their Activity against the Fish Pathogen Saprolegnia diclina.

Authors:  Yiying Liu; Christin Zachow; Jos M Raaijmakers; Irene de Bruijn
Journal:  Int J Mol Sci       Date:  2016-01-21       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.